Pro Football Prospects Training at TEST Sports Clubs(TM) Use SURGEX(TM) as Part of...

* Reuters is not responsible for the content in this press release.

Tue Jan 15, 2008 8:11pm EST

Pro Football Prospects Training at TEST Sports Clubs(TM) Use SURGEX(TM) as
Part of Their Pre-Combine Training Regime
NCAA Football Players Currently in Training and Preparing for the NFL Combine
Use SURGEX(TM) as part of their Training Program at TEST Sports Clubs(TM)

    BASKING RIDGE, N.J., Jan. 15 /PRNewswire-FirstCall/ -- Millennium
Biotechnologies Inc., wholly-owned subsidiary of Millennium Biotechnologies
Group, Inc. (OTC Bulletin Board: MBTG), announced today that SURGEX(TM) is
currently being administered as part of the nutritional program provided to
elite Division I & II Collegiate Football Athletes training for the NFL
Combine at TEST Sports Clubs(TM) (www.testsportsclubs.com) in Martinsville,
New Jersey.  Athletes preparing to enter the NFL Draft in April representing
teams from the SEC, ACC, Big Ten, Big XII and Big East are using the
SURGEX(TM) product as part of the Football Academy: NFL Combine Training at
TEST Sports Clubs.
    SURGEX(TM) is one of five co-sponsors of the NFL Combine Training Program
currently underway at TEST Sports Clubs.  Other co-sponsors include Under
Armor(R), EAS(R), Power Plate(R) and Amino Vital(R). TEST Sports Clubs Partner
and COO Kevin Dunn is proud to offer SURGEX(TM) to his athletes for their post
training nutritional needs, "TEST Sports Clubs are committed to providing only
premier, science based products and services to our athletes. SURGEX(TM)
represents the elite formula these athletes require to assist in proper
recovery following intense training sessions and workouts."
    Millennium's recently launched SURGEX(TM) product line is used by world
class collegiate and professional athletes in some of the most intense
athletic training programs in world. The SURGEX(TM) formula is certified by
the Banned Substance Control Group (BSCG) to contain no banned substances.
"As an alternative to stimulants and excess protein based products that
dominate the sports market, SURGEX(TM) represents true alternative formula
that addresses the multiple nutritional needs of the athlete.  With several
double blind, placebo controlled clinical trials in Division 1 athletes behind
it, SURGEX(TM) is the only nutritional formula shown to influence recovery,
strength, body composition and endurance parameters." states Millennium's Vice
President of Research and Product Development Carl Germano, RD, CNS, CDN.
"The success of SURGEX(TM) in sports is based upon the products ability to
help the athlete recover from the damaging effects of strenuous activity.  If
you can recover better, you can perform better. We view and treat the athlete
in the sports marketplace the same as we successfully do with critically ill
patients in the medical marketplace through optimized recovery and
rehabilitation."
    Headed by a distinguished staff of former Super Bowl Champions, NFL and
Collegiate standout performers and other strength and conditioning and
training specialists TEST Sports Clubs are one of the preeminent training
facilities in the country. The TEST Football Academy specializes in preparing
top collegiate football players for the annual NFL Combine.
    About SURGEX(TM):
    SURGEX(TM) (www.surgexsports.com) was created from Millennium's extensive
experience providing advanced nutritional formulas to some of the most
prestigious medical institutions throughout the United States The proprietary
SURGEX(TM) formula intends to meet the growing demand of elite level
professional and amateur athletes and their coaches looking for nutritional
support in a marketplace dominated by products with no clinical proof of
benefit, unsubstantiated claims, excess protein, stimulants, and banned
substances.
    In double blind placebo controlled trials at the Rutgers University Human
Performance Lab SURGEX(TM) significantly outperformed leading competitive
products by assisting in reducing the damaging effects of exercise by
improving peak power outputs, lowering oxidative stress/inflammatory markers,
reducing fatigue (poor energy recovery) and the breakdown of muscle (post
exercise wasting), as well as the lessening of free radical production
(oxidative stress). The formula meets NCAA guidelines for use by collegiate
athletes and is certified by The Banned Substances Control Group (BSCG) to
contain no banned substances.
    About Millennium:
    Millennium's three proprietary, marketed products, which form the
Company's Resurgex(R) Continuum of Care, include Resurgex Select(R),
Resurgex(R), and Resurgex Plus(R). Resurgex Select(R) is a whole foods-based,
calorically dense, high-protein nutritional formula developed for cancer
patients undergoing chemotherapy or radiation treatments. Resurgex(R) and
Resurgex Plus(R) are specialized, anabolic nutritional supplements rich in
antioxidants that provide nutritional support post-treatment. Millennium is
also recently developed a SURGEX(TM) sports nutrition formula, clinically
proven to address the nutritional concerns of both professional and amateur
elite athletes. These athletes often experience similar symptoms post-workout
to those battling immuno-compromised conditions, such as fatigue, loss of lean
muscle, oxidative stress, and reduced immune function.
    Statements in this news release regarding future financial and operating
results, future growth in R&D programs, potential applications of the
Company's technology, opportunities for the Company, and any other statements
about the future expectations, beliefs, goals, plans, or prospects expressed
constitute forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. Any statements that are not
statements of historical fact (including statements containing the words
"will," "believes," "plans," "anticipates," "expects," "estimates," and
similar expressions) should also be considered to be forward-looking
statements. There are a number of important factors that could cause actual
results or events to differ materially from those indicated by such forward-
looking statements including: limited operating history, need for future
capital, risks inherent in the development and commercialization of potential
products, protection of the Company's intellectual property, and economic
conditions generally. Additional information on potential factors that could
affect results and other risks and uncertainties are detailed from time to
time in the Company's periodic reports, including Forms 10-KSB, 10-QSB, 8-K,
and other forms filed with the Securities and Exchange Commission ("SEC").
These statements have not been evaluated by the Food and Drug Administration.
Resurgex(R), Resurgex Plus(R), Resurgex Select(R) and SURGEX(TM) are not
intended to diagnose, treat, cure, or prevent and disease.
SOURCE  Millennium Biotechnologies Inc.

John Swon of Millennium Biotechnologies Inc., +1-908-604-2500,
joswon@milbiotech.com
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.